8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)
Published . Updated .
Key takeaways
- 8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
- Exposed: DRMA
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
Directly affected
- DRMA Dermata Therapeutics-15.9% 9d
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DRMA | +21.04% | +20.29% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-17 AccNo: 0001493152-26-052715 Size: 199 KB Item 8.01: Other Events
Source: sec-edgar
How far Dermata Therapeutics (DRMA) has moved since 17 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Dermata Therapeutics (DRMA) | three days earlier | +20.29% | final price |
| Dermata Therapeutics (DRMA) | five days earlier | +21.04% | final price |
Who gains and who loses around Dermata Therapeutics (DRMA)
Companies carried with this story
- DRMA Dermata Therapeutics
In “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer),” Dermata Therapeutics (DRMA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DRMA
How “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” reaches Dermata Therapeutics (DRMA)
Dermata Therapeutics (DRMA) is the company in “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer),” the 17 Nov 2026 this story story.
For Dermata Therapeutics (DRMA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> DRMA
Price levels for Dermata Therapeutics (DRMA)
DRMA traded between 0.71 and 0.91 across 9 sessions. The latest close on file is 0.71.
How strong the case is around Dermata Therapeutics (DRMA)
14 out of 100
“8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.